AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 251 min read$TWST

Green Paula sold $189K of TWST

Green Paula (SVP of Human Resources) sold 1,360 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.19M total) on 2026-08-21.

Original reporting
SEC EDGAR · Green Paula
Published Aug 25, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TWST
Neutral
high confidence
Mentioned
$TWST
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TWSTNeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to affect stock valuation.

02

Market read

Limited relevance; typical insider sell with modest monetary value.

03

What to watch

Potential upcoming corporate actions or performance issues not yet disclosed.

Relevance 4/10Novelty 4/10Timing: post-filing 2026-08-25

Background

Twist Bioscience is a synthetic DNA manufacturer; insider transactions are regularly reported via Form 4.

Company-level read

Ticker impact

$TWSTNeutralHigh confidence
Context

Form 4 disclosed SVP of HR sold 1,360 shares for $189K, reducing holdings to 117,921 shares.

Expected impact

No significant impact; potential slight downward pressure.

Evidence & confidence

Sale size is modest relative to float and insider ownership; no broader implications.

Market effects

Sector

None; HR executive sale does not affect biotech sector.

Regional

None; limited to US market where TWST trades.

Global

Minimal; isolated insider transaction.

Counterpoint

What could challenge this read

Even small insider sells can signal concerns; monitor for further disposals.

Key entities

  • Individual
    Green Paula

    SVP of Human Resources at Twist Bioscience, reported insider sale.

  • Company
    Twist Bioscience Corp

    Biotech company (ticker TWST) subject of the insider transaction.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TWST insider trading history →

Related articles

OCT 5
$TWSTHigh

Twist Bioscience TWST Stock Jumps On AI Drug Discovery Deals

Twist Bioscience (TWST) stock rose 10.19% after announcing AI drug discovery deals with Eli Lilly's TuneLab. The company reported $118.4M in quarterly revenue, a $35.1M net loss, and positive operating cash flow of $1.1M. Analysts have raised price targets, with Guggenheim setting it at $212. TWST is seen as a key player in AI-driven biotech.

timothysykes.com3 min
SEP 24
$TWSTMed

Twist Bioscience Stock Jumps As Lilly AI Deal Fuels Bullish Target Hike

Twist Bioscience (TWST) stock rose 16.21% after announcing a partnership with Eli Lilly's AI drug discovery platform, TuneLab. The company reported Q3 revenue of $118.4M, with a gross margin of 52% but a net loss of $35.1M. Leerink raised its price target to $160, citing the AI-driven opportunity. TWST is trading at a high valuation with a price-to-sales ratio over 25.

timothysykes.com3 min
SEP 24
$TWSTMed

Twist Bioscience Stock Jumps As AI Deals Fuel Bullish Target Hike

Twist Bioscience (TWST) stock rose 8.35% on September 24, 2026, driven by its AI partnership with Eli Lilly's TuneLab platform. The company's stock has seen significant gains recently, trading at $171.74 from $139 over a few weeks. TWST reported quarterly revenue of $118.38M, with a net loss of $35.05M. Leerink raised its price target to $160, citing AI drug discovery opportunities.

timothysykes.com3 min